Susquehanna attributes the weakness in shares of Omnicare (NYSE:OCR) and PharMerica (NYSE:PMC) to concerns that their proposed merger may be the subject of a closed door enforcement action meeting at the FTC this afternoon. The FTC posted on its website a closed meeting for this afternoon, which has some speculating the meeting is about the transaction between Omnicare and PharMerica, Susquehanna says. However, the firm points out that there have been other closed door meetings where the topic has been vastly different from what the financial market assumed. Omnicare is currently above its 50-day moving average (MA) of $32.72 and above its 200-day of $30.37.
